Cell2Cure
  • Home
  • The Company
  • Research, Technology and IP
    • Background
  • Clinical
  • Investor and Partners
  • News
  • Contact us
Select Page

The Danish Medicines Agency has approved the phase I clinical trial with cell treatment of children with autism and leaky gut syndrome

by Backoffice | Nov 30, 2022 | Trial results

The Danish Medicines Agency has November 23rd, 2022, approved the un-blinded phase I dose-titrating clinical trial where children with autism and signs of leaky gut syndrome are treated with allogeneic adipose-derived mesenchymal stem cells (ASCs). The children will...

Publication of phase I results of ASC treatment of patients with radiation-induced Xerostomia

by Backoffice | Apr 29, 2022 | Trial results

The objective of the phase I clinical trial was to evaluate safety and provide proof of concept for efficacy of allogeneic adipose tissue-derived mesenchymal stromal cells (ASCs) injected into the major salivary glands in cancer patients with salivary glands damaged...

Publication of phase I trial results – ASC treatment in Sjögren’s syndrome

by Backoffice | Jan 14, 2020 | Trial results

The clinical phase I study evaluated the safety and feasibility of injecting allogeneic adipose-derived mesenchymal stem cells (ASCs) into the lacrimal gland as a treatment of aqueous deficient dry eye disease (ADDE) Sjögrens syndrome. The study found injection of...

Recent Posts

  • The Danish Medicines Agency has approved the phase I clinical trial with cell treatment of children with autism and leaky gut syndrome
  • Ethical approval for the ASC phase I clinical trial in children with autism and leaky gut syndrome
  • Cell2Cure has received approval from the Danish Medicinal Agency for a clinical Phase I study
  • The Cell2Cure core technology has been granted patent rights in Australia
  • Patient enrollment finalized in the Phase II trial testing ASC in Sjögren’s syndrome

Recent Comments

    Archives

    • November 2022
    • September 2022
    • August 2022
    • June 2022
    • April 2022
    • February 2022
    • July 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • January 2020

    Categories

    • Collaborations
    • Patents
    • Studies and testing
    • Trial results

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    © 2021 Cell2Cure | CVR.no 39401975 | Designed by ICR-Design ApS